Qube Research & Technologies Ltd

Position in WVE — Wave Life Sciences, Inc.

CIK 1729829 LONDON, X0

Position in WVE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$16,128,560

+$14,998,111 QoQ

Shares Held

2,776,000

+1680.4% QoQ

Ownership

1.41%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#15

of 237 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. WVE ranks #32 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$16,128,560	2,776,000	+1680.4%	Shares	Sole	2026-08-14
2026-03-31	$1,130,449	155,924	+21.8%	Shares	Sole	2026-05-15
2025-09-30	$936,835	127,983	-78.4%	Shares	Sole	2025-11-14
2025-06-30	$3,843,996	591,384	+57.8%	Shares	Sole	2025-08-14
2025-03-31	$3,028,901	374,864	+1137.3%	Shares	Sole	2025-05-15
2024-12-31	$374,773	30,297	-55.5%	Shares	Sole	2025-02-14
2024-09-30	$557,936	68,041	+61.1%	Shares	Sole	2024-11-14
2024-03-31	$260,515	42,223	-75.0%	Shares	Sole	2024-05-14
2023-03-31	$730,141	168,624	+124.0%	Shares	Sole	2023-05-15
2022-12-31	$526,974	75,282	+247.1%	Shares	Sole	2023-02-14
2022-09-30	$78,290	21,687	+63.2%	Shares	Sole	2022-11-14
2022-06-30	$43,182	13,287	-55.5%	Shares	Sole	2022-08-15
2021-03-31	$167,570	29,870	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.